Agency Forms Undergoing Paperwork Reduction Act Review, 36556-36558 [2021-14751]
Download as PDF
36556
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
characteristics, medical care, HIV
testing, pre-exposure prophylaxis,
antiretroviral treatment, sexually
transmitted diseases (STD) history,
symptoms of early HIV infection,
substance use and sexual behavior.
Data from the surveys will be merged
with HIV test results and relevant
clinical data using the unique
identification (ID) number. Data will be
stored on a secure server managed by
the awardee’s Information Technology
(IT) Services. The participation of
respondents is voluntary. There is no
cost to the respondents other than their
time. The total estimated annual burden
hours for the proposed project are 1,594
hours.
become concordant (i.e., at the last
Phase 2 visit) participants will complete
the Phase 2 Behavioral Survey to
identify any behavioral changes during
follow-up. Of the 50 Phase 2
participants; it is estimated that no more
than 26, annually, will have early HIV
infection.
All data for the proposed information
collection will be collected via an
electronic Computer Assisted SelfInterview (CASI) survey. Participants
will complete the surveys on an
encrypted computer, with the exception
of the Phase 2 Symptom and Care
survey, which will be administered by
a research assistant and then
electronically entered into the CASI
system. Data to be collected via CASI
include questions on sociodemographic
(indicating one or more false-positive
test results in Phase 1).
The follow-up schedule will consist
of up to nine visits scheduled at regular
intervals over a 70-day period. At each
follow-up visit, participants will be
tested with the new HIV tests and
additional oral fluid and blood
specimens will also be collected for
storage and use in future HIV test
evaluations at CDC. Participants will be
followed only to the point at which all
their test results become concordant. At
each time point, participants will be
asked to complete the Phase 2 HIV
Symptom and Care survey to collect
information on symptoms associated
with early HIV infection as well as
access to HIV care and treatment since
the last Phase 2 visit. When all tests
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Persons eligible for
study.
Enrolled participants ......
Phase 1 Consent .................................................
2,334
1
15/60
584
Phase
Phase
Phase
Phase
Enrollment Survey .................................
Consent .................................................
HIV Symptom and Care survey ............
Behavioral Survey .................................
1,867
50
50
50
1
1
9
1
30/60
15/60
5/60
30/60
934
13
38
25
Total ........................
..............................................................................
........................
........................
........................
1,594
1
2
2
2
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–14754 Filed 7–9–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–21–1242]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Strengthening
U.S. Response to Resistant Gonorrhea
(SURRG) to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on
September 30, 2020 to obtain comments
from the public and affected agencies.
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
CDC received one non-substantive
comment related to the previous notice.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Strengthening U.S. Response to
Resistant Gonorrhea (SURRG) (OMB
Control No. 0920–1242, Exp. 9/30/
2021)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
E:\FR\FM\12JYN1.SGM
12JYN1
36557
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
khammond on DSKJM1Z7X2PROD with NOTICES
Background and Brief Description
The purposes of Strengthening U.S.
Response to Resistant Gonorrhea
(SURRG) are to: (1) Improve national
capacity to detect, monitor, and respond
to the emerging threat of antibioticresistant gonorrhea, (2) understand
trends in and factors contributing to
antibiotic-resistant gonorrhea, and (3)
build a robust evidence-base for public
health action. This information
collection is important because: (1)
Effective treatment of gonorrhea is
critical to gonorrhea control and
prevention, (2) untreated or
inadequately treated gonorrhea can
cause serious reproductive health
complications, such as infertility, (3)
Neisseria gonorrhoeae (the bacterium
that causes gonorrhea) has consistently
demonstrated the ability to develop
resistance to the antibiotics used for
treatment and may be developing
resistance to the last remaining
treatment option recommended by the
Centers for Disease Control and
Prevention (CDC), and (4) antibioticresistant gonorrhea is extremely difficult
to detect without enhanced surveillance
and public health activities, such as
SURRG, because healthcare providers
rarely perform or have access to
resistance testing for individual
patients.
SURRG supports rapid detection of
resistant gonorrhea and gets actionable
information into the hands of healthcare
providers (to support appropriate
treatment of individual patients) and
local health departments (to support
rapid public health response to slow the
spread of resistant infections in the
community). Jurisdictions participating
in SURRG applied as part of a
competitive process and participate
voluntarily. As an overview of SURRG,
healthcare providers at participating
clinics (sexually transmitted disease
[STD] clinics affiliated with a single
public health department or other
participating non-STD clinic sites)
collect specimens for N. gonorrhoeae
culture testing from men and women
seeking care for possible gonorrhea.
Specimens that demonstrate N.
gonorrhoeae (called ‘‘isolates’’) undergo
antibiotic resistance testing within
several days at a local public health
laboratory. Laboratory results
demonstrating resistance are rapidly
communicated by the laboratory staff to
the healthcare provider and designated
health department staff member, who
initiates a field investigation. The
patient (from whom the resistant
specimen was collected) is interviewed
about risk factors and recent contacts,
and will be re-tested to ensure that they
were cured. Recent contacts are
interviewed by the health department
(contact tracing) and tested for
gonorrhea. The participating health
departments collect and transmit to CDC
demographic and clinical data about
persons tested for, and diagnosed with
gonorrhea in the participating clinics,
results of local antibiotic resistance
testing, and information about field
investigations. None of the data
transmitted to CDC contains any
personally identifiable information.
These data are used by CDC to
monitor resistance, understand risk
factors for resistance, and identify the
most effective approaches to prevent the
spread of resistance. Data are
transmitted through CDC’s Secure
Access Management Services (SAMS).
SAMS is an approved federal
information technology system that
provides authorized and validated users
secure and encrypted access to CDC file
transfer applications. The encrypted
data are stored in a secure CDC server
with strictly controlled and restricted
access rights. Isolates are shipped each
month to one of four Antibiotic
Resistance Regional Laboratory Network
(ARLN) laboratories for confirmatory
antibiotic susceptibility testing and
molecular characterization. The isolates
only contain bacterial DNA (and not
human DNA).
Under the SURRG protocol, the local
SURRG data managers from each of the
funded jurisdictions abstract STD clinic
data for patients tested for gonorrhea,
receive data from non-STD clinic
healthcare sites about persons tested for
gonorrhea, receive resistance testing
laboratory results from local public
health laboratories, abstract data about
field investigations, and merge the data.
Every two months, the local SURRG
data manager cleans the data, removes
personally identifiable information, and
transmits the data to CDC. We estimate
these data processes will take 16 hours
every two months. Annually, the local
SURRG data manager will send a final
cumulative data file, so a total of seven
data transmissions/responses will occur.
Every two months, data managers at
each of the participating non-STD clinic
health centers abstract and clean data
and securely transmits the data to the
local SURRG data manager. We estimate
that it will take three hours each time
data managers at each non-STD SURRG
location abstract, clean, and transmit
SURRG data.
Microbiologists at public health
laboratories from each of the eight
SURRG funded jurisdictions conduct
antibiotic resistance testing on all N.
gonorrhoeae isolates from all STD clinic
sites and non-STD clinic sites
participating in SURRG. Each test takes
approximately 10 minutes of staff time,
and testing of control strains is also
conducted approximately twice per
week at each laboratory. On average,
each jurisdiction conducts
approximately 600 resistance tests per
year for patient care, plus 100 control
strains per year for quality assurance.
Thus, a total of approximately 700 tests
per year per grantee are performed.
Every two months, a laboratory data
manager abstracts test results and
securely sends the datafile to the local
SURRG data manager. We estimate that
laboratory data managers spend
approximately one hour each time they
abstract, clean, and transmit project
data.
Health department staff will
interview: Any person diagnosed with
antibiotic-resistant gonorrhea or have a
case of gonorrhea of public health
significance index case, and their sexual
contacts. On average, each jurisdiction
will identify four drug-resistant isolates
each month. These isolates will spur
field investigations, which will result in
six additional interviews each month.
We estimate a total of 120 interviews
will occur annually at each site, for a
total across the 8 sites of 960 interviews
each year. Each interview will take
approximately 20 minutes.
The total estimated annual burden
hours are 2,665. There are no additional
costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Local SURRG data manager ..........................
Facility Data Elements ...................................
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Number of
respondents
Type of respondents
E:\FR\FM\12JYN1.SGM
8
12JYN1
7
Average
burden per
response
(in hours)
16
36558
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Average
burden per
response
(in hours)
Form name
Data manager at non-STD clinic health centers.
Public Health Laboratory Microbiologist .........
Public Health Laboratory Data Manager ........
Gonorrhea Patients and Sexual Contacts ......
Non-STD clinic Data Elements ......................
26
6
3
Laboratory Testing Data Elements ................
Laboratory Data Elements .............................
Field Investigation Data Elements .................
8
8
960
700
6
1
10/60
1
20/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
Stephen Antkowiak, Office of Refugee
Resettlement, Division of
Unaccompanied Alien Children
Operations, 330 Street SW, Washington,
DC 20447. Phone: 202–260–6165. Email:
stephen.antkowiak@acf.hhs.gov.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Announcement of Intent To Issue One
Operating Division (OPDIV)-Initiated
Supplement to BCFS Health and
Human Services Under the Standing
Announcement for Residential
(Shelter) Services for Unaccompanied
Alien Children, HHS–2017–ACF–ORR–
ZU–1132
Unaccompanied Alien
Children’s (UAC) Program, Office of
Refugee Resettlement (ORR),
Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
AGENCY:
Notice of intent to issue one
OPDIV-Initiated Supplement to BCFS
Health and Human Services (BCFS
HHS), San Antonio, Texas under the
UAC Program.
ACTION:
ACF, ORR, announces the
issuance of one OPDIV-Initiated
Supplement to BCFS HHS, San Antonio,
Texas in the amount of up to
$475,868,102. ORR has been identifying
additional capacity to provide shelter
for potential increases in apprehensions
of UAC at the Southwest Border.
Planning for increased shelter capacity
is a prudent step to ensure that ORR is
able to meet its responsibility, by law,
to provide shelter for UAC referred to its
care by the Department of Homeland
Security. To ensure sufficient capacity
to provide shelter to UAC referred to
HHS, ORR is requesting that BCFS HHS
continue the use of up to 1008 hardsided beds at Carrizo Springs, Texas.
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
ORR is
continuously monitoring its capacity to
shelter the UAC referred to HHS, as well
as the information received from
interagency partners, to inform any
future decisions or actions.
ORR has specific requirements for the
provision of services. Award recipients
must have the infrastructure, licensing,
experience, and appropriate level of
trained staff to meet those requirements.
The expansion of the existing program
and its services through this
supplemental award is a key strategy for
ORR to be prepared to meet its
responsibility to provide shelter for
UAC referred to its care by the
Department of Homeland Security
(DHS), and so the Customs and Border
Protection can continue its vital
national security mission to prevent
illegal migration, trafficking, and protect
the borders of the United States.
Statutory Authority: This program is
authorized by—
(A) Section 462 of the Homeland
Security Act of 2002, which in March
2003, transferred responsibility for the
care and custody of UAC from the
Commissioner of the former
Immigration and Naturalization Service
to the Director of ORR within HHS.
(B) The Flores Settlement Agreement,
Case No. CV85–4544–RJK (C.D. Cal.
1996), as well as the William
Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008
(Pub. L. 110–457), which authorizes
post release services under certain
conditions to eligible children. All
programs must comply with the Flores
Settlement Agreement, Case No. CV85–
4544–RJK (C.D. Cal. 1996); pertinent
SUPPLEMENTARY INFORMATION:
[CFDA Number: 93.676]
SUMMARY:
Supplemental award funds will
support activities until January 31,
2022.
DATES:
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2021–14751 Filed 7–9–21; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
regulations; and ORR policies and
procedures.
Elizabeth Leo,
Senior Grants Policy Specialist, Office of
Grants Policy, Office of Administration.
[FR Doc. 2021–14722 Filed 7–7–21; 4:15 pm]
BILLING CODE 4184–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
[OMB# 0985–New]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Evidence Based
Program Fidelity Surveys
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity for the public to
comment on the proposed collection of
information listed above. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish a notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection requirements
relating to a Grantee Survey and a Local
Implementation Organization Survey
that will be used by ACL to evaluate the
fidelity with which ACL and its grantee
organizations, under the Older
Americans Act, implement the required
evidence-based programs.
DATES: Comments on the collection of
information must be submitted
electronically by 11:59 p.m. (EST) or
postmarked by September 10, 2021.
ADDRESSES: Submit electronic
comments on the collection of
information to: Susan.Jenkins@
acl.hhs.gov. Submit written comments
on the collection of information to
SUMMARY:
E:\FR\FM\12JYN1.SGM
12JYN1
Agencies
[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36556-36558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-21-1242]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Strengthening U.S. Response to Resistant
Gonorrhea (SURRG) to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
September 30, 2020 to obtain comments from the public and affected
agencies. CDC received one non-substantive comment related to the
previous notice. This notice serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Strengthening U.S. Response to Resistant Gonorrhea (SURRG) (OMB
Control No. 0920-1242, Exp. 9/30/2021)--Revision--National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
[[Page 36557]]
Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The purposes of Strengthening U.S. Response to Resistant Gonorrhea
(SURRG) are to: (1) Improve national capacity to detect, monitor, and
respond to the emerging threat of antibiotic-resistant gonorrhea, (2)
understand trends in and factors contributing to antibiotic-resistant
gonorrhea, and (3) build a robust evidence-base for public health
action. This information collection is important because: (1) Effective
treatment of gonorrhea is critical to gonorrhea control and prevention,
(2) untreated or inadequately treated gonorrhea can cause serious
reproductive health complications, such as infertility, (3) Neisseria
gonorrhoeae (the bacterium that causes gonorrhea) has consistently
demonstrated the ability to develop resistance to the antibiotics used
for treatment and may be developing resistance to the last remaining
treatment option recommended by the Centers for Disease Control and
Prevention (CDC), and (4) antibiotic-resistant gonorrhea is extremely
difficult to detect without enhanced surveillance and public health
activities, such as SURRG, because healthcare providers rarely perform
or have access to resistance testing for individual patients.
SURRG supports rapid detection of resistant gonorrhea and gets
actionable information into the hands of healthcare providers (to
support appropriate treatment of individual patients) and local health
departments (to support rapid public health response to slow the spread
of resistant infections in the community). Jurisdictions participating
in SURRG applied as part of a competitive process and participate
voluntarily. As an overview of SURRG, healthcare providers at
participating clinics (sexually transmitted disease [STD] clinics
affiliated with a single public health department or other
participating non-STD clinic sites) collect specimens for N.
gonorrhoeae culture testing from men and women seeking care for
possible gonorrhea. Specimens that demonstrate N. gonorrhoeae (called
``isolates'') undergo antibiotic resistance testing within several days
at a local public health laboratory. Laboratory results demonstrating
resistance are rapidly communicated by the laboratory staff to the
healthcare provider and designated health department staff member, who
initiates a field investigation. The patient (from whom the resistant
specimen was collected) is interviewed about risk factors and recent
contacts, and will be re-tested to ensure that they were cured. Recent
contacts are interviewed by the health department (contact tracing) and
tested for gonorrhea. The participating health departments collect and
transmit to CDC demographic and clinical data about persons tested for,
and diagnosed with gonorrhea in the participating clinics, results of
local antibiotic resistance testing, and information about field
investigations. None of the data transmitted to CDC contains any
personally identifiable information.
These data are used by CDC to monitor resistance, understand risk
factors for resistance, and identify the most effective approaches to
prevent the spread of resistance. Data are transmitted through CDC's
Secure Access Management Services (SAMS). SAMS is an approved federal
information technology system that provides authorized and validated
users secure and encrypted access to CDC file transfer applications.
The encrypted data are stored in a secure CDC server with strictly
controlled and restricted access rights. Isolates are shipped each
month to one of four Antibiotic Resistance Regional Laboratory Network
(ARLN) laboratories for confirmatory antibiotic susceptibility testing
and molecular characterization. The isolates only contain bacterial DNA
(and not human DNA).
Under the SURRG protocol, the local SURRG data managers from each
of the funded jurisdictions abstract STD clinic data for patients
tested for gonorrhea, receive data from non-STD clinic healthcare sites
about persons tested for gonorrhea, receive resistance testing
laboratory results from local public health laboratories, abstract data
about field investigations, and merge the data. Every two months, the
local SURRG data manager cleans the data, removes personally
identifiable information, and transmits the data to CDC. We estimate
these data processes will take 16 hours every two months. Annually, the
local SURRG data manager will send a final cumulative data file, so a
total of seven data transmissions/responses will occur. Every two
months, data managers at each of the participating non-STD clinic
health centers abstract and clean data and securely transmits the data
to the local SURRG data manager. We estimate that it will take three
hours each time data managers at each non-STD SURRG location abstract,
clean, and transmit SURRG data.
Microbiologists at public health laboratories from each of the
eight SURRG funded jurisdictions conduct antibiotic resistance testing
on all N. gonorrhoeae isolates from all STD clinic sites and non-STD
clinic sites participating in SURRG. Each test takes approximately 10
minutes of staff time, and testing of control strains is also conducted
approximately twice per week at each laboratory. On average, each
jurisdiction conducts approximately 600 resistance tests per year for
patient care, plus 100 control strains per year for quality assurance.
Thus, a total of approximately 700 tests per year per grantee are
performed. Every two months, a laboratory data manager abstracts test
results and securely sends the datafile to the local SURRG data
manager. We estimate that laboratory data managers spend approximately
one hour each time they abstract, clean, and transmit project data.
Health department staff will interview: Any person diagnosed with
antibiotic-resistant gonorrhea or have a case of gonorrhea of public
health significance index case, and their sexual contacts. On average,
each jurisdiction will identify four drug-resistant isolates each
month. These isolates will spur field investigations, which will result
in six additional interviews each month. We estimate a total of 120
interviews will occur annually at each site, for a total across the 8
sites of 960 interviews each year. Each interview will take
approximately 20 minutes.
The total estimated annual burden hours are 2,665. There are no
additional costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Local SURRG data manager.............. Facility Data Elements.. 8 7 16
[[Page 36558]]
Data manager at non-STD clinic health Non-STD clinic Data 26 6 3
centers. Elements.
Public Health Laboratory Laboratory Testing Data 8 700 10/60
Microbiologist. Elements.
Public Health Laboratory Data Manager. Laboratory Data Elements 8 6 1
Gonorrhea Patients and Sexual Contacts Field Investigation Data 960 1 20/60
Elements.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-14751 Filed 7-9-21; 8:45 am]
BILLING CODE 4163-18-P